Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | PDGF-BB | 26.0 | 67 | |
RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | PDGF-BB | 25.0 | 47 | |
RA2159 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | PDGF-BB | 23.0 | 70 | |
N2586 | Visfatin | 1 | ng/mL | 1 | PDGF-BB | 23.5 | 64 | ||||
N2586 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | PDGF-BB | 28.0 | 65 | |
N2586 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | PDGF-BB | 26.0 | 64 | |
N2586 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | PDGF-BB | 25.0 | 67 | |
N2586 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | PDGF-BB | 21.0 | 51 | |
N2586 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | PDGF-BB | 22.0 | 49 | |
0 | PDGF-BB | 22.0 | 53 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 45.0 | 61 | ||||
RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 32.0 | 46 | |
RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 24.0 | 52 | |
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 30.5 | 32 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 34.0 | 78 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 23.0 | 73 | |
N2586 | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 37.5 | 46 | ||||
N2586 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 34.5 | 68 | |
N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 25.0 | 48 | |
N2586 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 33.0 | 39 | |
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 29.5 | 56 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 27.0 | 52 | |
0 | PDGF-BB | 29.0 | 61 | ||||||||
RA2159 | 2 | PDGF-BB | 27.0 | 64 | |||||||
RA2159 | EO1428 | 1.0 | uM | 2 | PDGF-BB | 27.0 | 86 |